Rare diseases
Investigational molecules
Locations
Back to Croatia257 clinical trials in Zagreb, Croatia across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time
CroatiaA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
CroatiaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
CroatiaStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
CroatiaStudy of evenamide as add-on treatment for patients with treatment-resistant schizophrenia not adequately controlled by current antipsychotic medications
CroatiaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
CroatiaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
CroatiaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
CroatiaStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
CroatiaStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
CroatiaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
CroatiaStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on autoimmune disorders encompass treatments for psoriatic arthritis, Sjögren's Syndrome, and systemic lupus erythematosus, evaluating novel therapeutic approaches for improved patient outcomes.
These trials aim to assess new biological medicines and their effectiveness in managing chronic inflammatory conditions.
Research initiatives targeting neurological conditions focus on multiple sclerosis and Alzheimer's disease-related psychosis, exploring innovative treatment approaches for better disease management.
Studies evaluate both established and emerging treatments to improve patient outcomes and quality of life.
Advanced cancer research programs examine treatments for lung cancer, leukemia, and thyroid cancer, investigating targeted therapies and combination treatments.
These trials focus on improving survival rates and developing more effective treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
